Market Overview

Estrogen Therapeutics: Global Markets to 2022 - Analysis on Key Players Abbott, Bayer, Novartis, Novo Nordisk, and Pfizer -


The "Global
Estrogen Therapeutics Market 2018-2022"
report has been added
to's offering.

The Global Estrogen Therapeutics Market is forecast to grow at a CAGR of
2.33% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with
inputs from industry experts. The report covers the market landscape and
its growth prospects over the coming years. The report also includes a
discussion of the key vendors operating in this market.

One trend affecting this market is the development of innovative
estrogen delivery systems New drug delivery systems such as transdermal
drug delivery has gained popularity in the global estrogen therapeutics
market. New drug delivery systems offer great flexibility, as these
authorize localized treatment of specific tissues and controlled release
methods for systematic delivery.

According to the report, one driver influencing this market is the
increasing awareness about treatment of menopausal symptoms. The
awareness about the negative impact of menopausal symptoms on the
quality of life varies widely between countries and societies. In
developed countries, such as the US, Canada, and Japan, and countries in
Europe, the knowledge regarding occurrence and impact of menopausal
symptoms and their treatment is widespread due to public literacy and
government health programs.

Further, the report states that one challenge affecting this market is
the health risks associated with estrogen therapy. There are some major
side effects and risks associated with estrogen therapeutics and HRTs,
which discourage their utilization among end consumers, thereby posing a
challenge for the growth of the market.

Key Vendors

  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Market Sizing

6. Five Forces Analysis

7. Market Segmentation by Product

8. Customer Landscape

9. Market Segmentation by Estrogen Type

10. Regional Landscape

11. Decision Framework

12. Drivers and Challenges

13. Market Trends

14. Vendor Landscape

15. Vendor Analysis

For more information about this report visit

View Comments and Join the Discussion!